Canada vs Poland: Reported rate of new cervical cancer cases
Canada
6.23 per 100,000 women
in 2017
Poland
6.3 per 100,000 women
in 2017
Canada rank
32nd
Poland rank
29th
Reported rate of new cervical cancer cases over time
- Canada
- Poland
How they compare
Poland currently reports 6.3 per 100,000 women against 6.23 per 100,000 women in Canada, a difference of 0.07 per 100,000 women.
The two have swapped places 2 times across 19 shared years of data; in 1999 it was Poland ahead.
Canada ranks 32nd and Poland ranks 29th of 46 countries.
Poland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.04 per 100,000 women | 14.72 per 100,000 women | 7.68 per 100,000 women | Poland |
| 2000s | 6.39 per 100,000 women | 12.37 per 100,000 women | 5.99 per 100,000 women | Poland |
| 2010s | 6.02 per 100,000 women | 7.88 per 100,000 women | 1.86 per 100,000 women | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Canada or Poland?
- Poland, at 6.3 per 100,000 women against 6.23 per 100,000 women in Canada as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Canada and Poland?
- 0.07 per 100,000 women, with Poland ahead.
- How many years of comparable data are there for Canada and Poland?
- 19 years are reported by both, from 1999 to 2017.
- How do Canada and Poland rank globally for reported rate of new cervical cancer cases?
- Canada ranks 32nd and Poland ranks 29th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.